INHERENT RESISTANCE IN REFRACTORY METASTATIC COLORECTAL CANCER TO EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODIES

被引：0
|
作者：
Galal, K. [1 ]
Zaghloul, K. [2 ]
Mourad, M. A. [3 ]
机构：
[1] Cairo Univ, Dept Oncol, Cairo, Egypt
[2] Tanta Univ, Dept Internal Med, Tanta, Egypt
[3] Assiut Univ, Dept Radiol, Assiut, Egypt
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：63 / 63
页数：1
相关论文
共 50 条
  • [31] Therapeutic strategies targeting the epidermal growth factor receptor signaling pathway in metastatic colorectal cancer
    Zhou, Yi
    Wu, Shuang
    Qu, Fan-Jie
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 16 (06) : 2362 - 2379
  • [32] Panitumumab in metastatic colorectal cancer patients with low/negative epidermal growth factor receptor levels
    Mitchell, E.
    Hecht, J.
    Baranda, J.
    Malik, I
    Richards, D.
    Navale, L.
    D'Avirro, P.
    Amado, R.
    ANNALS OF ONCOLOGY, 2006, 17 : 29 - 29
  • [33] Panitumumab activity in metastatic colorectal cancer patients with ≥10% epidermal growth factor receptor levels
    Chan, E.
    Neubauer, M.
    Swanson, P.
    Harker, W.
    Burris, H.
    Hecht, J.
    Navale, L.
    Brown, J.
    Amado, R.
    ANNALS OF ONCOLOGY, 2006, 17 : 68 - 68
  • [34] Anti-Epidermal Growth Factor Receptor Antibody Readministration in Chemorefractory Metastatic Colorectal Cancer
    Kajitani, Tatsuhiro
    Makiyama, Akitaka
    Arita, Shuji
    Shimokawa, Hozumi
    Oda, Hisanobu
    Shirakawa, Tsuyoshi
    Baba, Eishi
    Esaki, Taito
    ANTICANCER RESEARCH, 2017, 37 (11) : 6459 - 6468
  • [35] Relationship Between Colorectal Cancer Biomarkers and Response to Epidermal Growth Factor Receptor Monoclonal Antibodies
    Hawkes, Eliza
    Cunningham, David
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (28) : E529 - E531
  • [36] Liquid biopsy to detect resistance mutations against anti-epidermal growth factor receptor therapy in metastatic colorectal cancer
    Valenzuela, Guillermo
    Burotto, Mauricio
    Marcelain, Katherine
    Gonzalez-Montero, Jaime
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 14 (09) : 1654 - 1664
  • [37] Liquid biopsy to detect resistance mutations against anti-epidermal growth factor receptor therapy in metastatic colorectal cancer
    Guillermo Valenzuela
    Mauricio Burotto
    Katherine Marcelain
    Jaime González-Montero
    World Journal of Gastrointestinal Oncology, 2022, (09) : 1654 - 1664
  • [38] Natural History of Human Epidermal Growth Factor Receptor 2-Amplified and Human Epidermal Growth Factor Receptor 2 Wild-Type Refractory Metastatic Colorectal Cancer in US Clinical Practice
    Schroeder, Carsten
    Gower-Page, Craig
    Reyes-Rivera, Irmarie
    Patel, Arisha
    Price, Richard
    Sen, Shiraj
    Davies, Jessica
    Castellanos, Emily
    Snider, Jeremy
    Bai, Xiaobo
    Fisher, Virginia
    Mhatre, Shivani K.
    JCO CLINICAL CANCER INFORMATICS, 2022, 6
  • [39] Clinical impact of anti-epidermal growth factor receptor monoclonal antibodies in first-line treatment of metastatic colorectal cancer
    Loupakis, Fotios
    Cremolini, Chiara
    Salvatore, Lisa
    Schirripa, Marta
    Lonardi, Sara
    Vaccaro, Vanja
    Cuppone, Federica
    Giannarelli, Diana
    Zagonel, Vittorina
    Cognetti, Francesco
    Tortora, Giampaolo
    Falcone, Alfredo
    Bria, Emilio
    CANCER, 2012, 118 (06) : 1523 - 1532
  • [40] Epidermal growth factor receptor inhibition in metastatic anal cancer
    Rogers, Jane E.
    Ohinata, Aki
    Silva, Ninoska N.
    Mehdizadeh, Amir
    Eng, Cathy
    ANTI-CANCER DRUGS, 2016, 27 (08) : 804 - 808
12345